Communities across Australia rely on Registered Nurses (RNs) to provide primary care, acute care and aged care. They are skilled, capable and trusted healthcare practitioners often working in some of the most rural and remote parts of the country.
In March 2023, the Australian Government released the National Rural and Remote Nursing Generalist Framework 2023–2027. The Framework is a world first and describes the unique context of practice and core capabilities for rural and remote Registered Nurses in Australia.
As well as describing skills, capabilities and support needed by RNs, the Framework emphasises the importance of clinical decision-making judgement of the patient’s situation, culturally safe practice, collaboration, and partnerships with clients, families and communities.
The framework is for RNs who work in rural and remote locations across Australia, or are looking to relocate there. One such nurse who relocated is Clinton Archer, with Queensland Health, who was interviewed by Australian Health Journal for this segment.
Other ways the the Framework can be applied include:
- For Registered Nurses, mapping their development of the capabilities with a mentor, to develop from formative to proficient skill levels.
- For Educators and Education Providers, supporting individual skill development or curriculum based on the capabilities.
- Government, Organisations and Employers, using the Framework as a guide to grow and support the development of a skilled rural and remote RN workforce
The Framework was developed by the Office of the National Rural Health Commissioner and Australian Health Journal spoke with National Rural Health Commissioner, Adjunct Professor Ruth Stewart, and Deputy National Rural Health Commissioner – Nursing and Midwifery, Adjunct Professor Shelley Nowlan, on the importance of rural and remote nursing and of the Framework itself.
Important contributions and expertise of the members of the National Rural and Remote Nursing Generalist Framework Steering Committee (Steering Committee) led the Framework through its development and consultation. Steering Committee members represented the following organisations.
- Office of the National Rural Health Commissioner
- Australian Government Department of Health and Aged Care
- Australian and New Zealand Council of Chief Nursing and Midwifery Officers
- Australian College of Nurse Practitioners (ACNP)
- Australian College of Nursing (ACN)
- Australian Nursing and Midwifery Accreditation Council (ANMAC)
- Australian Nursing and Midwifery Federation (ANMF)
- Australian Primary Health Care Nurses Association (APNA)
- Congress of Aboriginal and Torres Strait Islander Nurses and Midwives (CATSINaM)
- Council of Deans of Nursing and Midwifery (CDNM)
- Council of Remote Area Nurses of Australia (CRANAplus)
- James Cook University
- Nursing and Midwifery Board of Australia (NMBA)
-
Outstanding Achievement
George FaithfullGeorge has been in the medical device industry in a variety of roles for over 35 years including Sales, Marketing, Business Development, General Management, R&D, Clinical, Regulatory and Government Affairs. He has worked for Stryker in Australia, USA and across Asia.
-
Impact of genetic pathologist role across medicine
Dr Marina Berbic is a genetic pathologist and the Deputy Director of Genetics at Douglass Hanly Moir Pathology – a laboratory based in Sydney and part of Sonic Healthcare. The genetics department at Douglass Hanly Moir offers a wider array of genetic tests across many domains, and the medical leadership model ensures the highest possible standard of care and commitment to patient safety.
-
The role of genomic screening in transforming public health
Dr Jane Tiller is a lawyer, genetic counsellor and public health researcher. She is Ethical, Legal & Social Adviser in Public Health Genomics at Monash University, and a National Health and Medical Research Council Investigator Grant holder. Jane is passionate about the use of genomics to prevent disease, and in delivering equitable access to preventive genetic information at the population level. She is co-lead of DNA Screen, a world-first study piloting the offer of preventive DNA screening to the Australian adult population. DNA Screen has tested over 10,000 young people for genetic high risk of medically actionable conditions such as cancer and heart disease, finding about 2% of participants had genetic high risk. Jane is leading efforts to secure Commonwealth Government funding to expand the DNA Screen program, with the eventual goal of the development of a public health population screening program for disease prevention based on high genetic risk.
